What does Tonix Pharmaceuticals Holding Corp. (TNXP) do?

Tonix Pharmaceuticals Holding Corp. (TNXP) is a publicly traded company.

What sector does TNXP operate in?

Tonix Pharmaceuticals Holding Corp. operates in the equity market. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find TNXP earnings analysis?

AlphaOS publishes an earnings intelligence page for Tonix Pharmaceuticals Holding Corp. (TNXP) covering results, guidance context, and AI-assisted analysis. See /stocks/TNXP/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

TNXP

Tonix Pharmaceuticals Holding Corp.

$9.90Sep 28, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

Tonix Pharmaceuticals Holding Corp. shows accelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue +577% YoY in Q2 FY2026.

TrajectoryAccelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue +577% YoY in Q2 FY2026

Pipeline evidence · 1d ago

TNXP's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on TNXP.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full TNXP earnings analysis

Reported figures for Tonix Pharmaceuticals Holding Corp. — research only, not investment advice.

Revenue YoY: +577.0%

Latest Intelligence

Updated September 29, 2026

What happened recently for Tonix Pharmaceuticals Holding Corp. (TNXP) — events, not interpretation.

Event: Reported Q2 2026 revenue +577% YoY.
Also: Last session September 28, 2026 at $9.9.
Source: Q2 2026 earnings

Research & analysis only — not investment advice.

Loading earnings intelligence…

Tonix Pharmaceuticals Holding Corp. (TNXP)

US equity research on AlphaOS

Investment Snapshot above is the primary AlphaOS analysis for Tonix Pharmaceuticals Holding Corp. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Market cap:: $169.80M
Revenue:: $13.11M

TNXP earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Tonix Pharmaceuticals Holding Corp. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.